According to a June 9, 2026, Reuters report, world markets have swung sharply over the past week, reflecting heightened uncertainty about the economic outlook.
Keep Reading →
June 18 - Hedge Funds, News
On May 27, Kathleen Entwistle, Morgan Stanley Private Wealth Management Managing Director & Private Wealth Advisor, joined 'Fast Money' on CNBC to talk about buying opportunities...
Keep Reading →
May 31 - Hedge Funds, News
On May 29, Reuters reported that the Russell 2000 fell 0.6%, lagging the broader Wall Street indexes, which closed at new highs.
Keep Reading →
May 31 - Hedge Funds, News
ADMA Biologics, Inc. (NASDAQ:ADMA) is one of the best small cap stocks to buy for 10x potential. On May 7, Mizuho lowered the price target on ADMA Biologics, Inc.
Keep Reading →
May 14 - News
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best healthcare stocks to buy for the long term. Canaccord cut the price target on ADMA Biologics Inc.
Keep Reading →
May 12 - News
On May 11, Dan Niles, Niles Investment Management founder, appeared on CNBC’s ‘The Exchange’ to talk about his view on equity markets while conducting a comparison with ...
Keep Reading →
May 12 - Hedge Funds, News
On May 7, Haig Bathgate, CEO of Callanish Capital, appeared on CNCB to talk about his bullish view on the global markets amid the Iran war, and how its impact would be short-lived...
Keep Reading →
May 10 - Hedge Funds, News
Operator: Good afternoon, and welcome to the ADMA Biologics First Quarter 2026 Financial Results and Business Update Conference Call on Wednesday, May 6, 2026.
Keep Reading →
May 8 - News, Transcripts
TheFly reported on April 21 that Canaccord Genuity initiated coverage of ADMA with a Buy rating and set a price target of $21.
Keep Reading →
April 24 - News
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more...
Keep Reading →
April 23 - Hedge Funds, News
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the best low priced biotech stocks to invest in. Mizuho cut the price target on ADMA Biologics Inc.
Keep Reading →
April 19 - News
ADMA Biologics Inc. (NASDAQ:ADMA) is one of the most undervalued biotech stocks to buy right now. Cantor Fitzgerald downgraded ADMA Biologics Inc.
Keep Reading →
April 19 - News
On April 13, Tom Lee, Fundstrat's head of research, appeared on CNBC’s 'Power Lunch' to talk about his outlook on equities, what to expect in a wartime economy, and more.
Keep Reading →
April 18 - Hedge Funds, News
On April 16, Fundstrat’s Tom Lee appeared on CNBC's 'Closing Bell' to talk about what to expect from equity markets going forward.
Keep Reading →
April 18 - Hedge Funds, News
On April 9, Tom Lee, Head of Research at Fundstrat, appeared on a CNBC Television interview to discuss market conditions as the war between the US and Iran had started to cool...
Keep Reading →
April 11 - Hedge Funds, News
ADMA Biologics snapped a five-day losing streak on Friday, soaring 11.58 percent to finish at $9.25 apiece after debunking a short seller report that criticized the company for...
Keep Reading →
March 28 - News
Meanwhile, Wall Street’s three major indices all finished in the red, with the Nasdaq leading the drop by 2.15 percent.
Keep Reading →
March 27 - Market Movers, News
On March 9, Allan Small, Senior Investment Advisor for Allan Small Financial Group at iA Private Wealth, appeared on BNN Bloomberg to discuss the extreme volatility of oil prices...
Keep Reading →
March 23 - Hedge Funds, News
We came across a bullish thesis on ADMA Biologics, Inc. on Stockmindsweb’s YouTube Channel. In this article, we will summarize the bulls’ thesis on ADMA.
Keep Reading →
January 14 - News, Stock Analysis
For more than a century, investing in the stock market in the United States has represented one of the most accessible paths to generating substantial wealth for the amateur investor...
Keep Reading →
December 18 - Hedge Funds, News
Operator: Good afternoon, and welcome to the ADMA Biologics Third Quarter 2025 Financial Results and Business Update Conference Call on Wednesday, November 5 2025.
Keep Reading →
November 7 - News, Transcripts
Renaissance Investment Management, an investment management company, released its Q2 2025 “Small Cap Growth Strategy” investor letter.
Keep Reading →
September 22 - Hedge Fund Investor Letters, News
We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA.
Keep Reading →
August 27 - News, Stock Analysis
ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2025 Earnings Call Transcript August 6, 2025ADMA Biologics, Inc. beats earnings expectations.
Keep Reading →
August 8 - News, Transcripts
[caption id="attachment_1205788" align="aligncenter" width="1456"] An independent distributor in their pharmacy with a range of biopharmaceutical products on display.[/caption...
Keep Reading →
July 23 - News
The current market is witnessing political chess moves, which are also affecting policy changes.
Keep Reading →
July 21 - Hedge Funds, Market Movers, News
ADMA Biologics fell by 14.7 percent week-on-week, closing Friday at $17.74 versus the $20.81 on June 13, as investors took path from three of its executives’ recent disposition...
Keep Reading →
June 24 - News
ADMA Biologics saw its share prices decline by 4.02 percent on Wednesday to finish at $18.13 apiece, as investors parked funds amid the lack of fresh catalysts to spark buying...
Keep Reading →
June 19 - News
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript May 7, 2025ADMA Biologics, Inc. misses on earnings expectations.
Keep Reading →
May 8 - News, Transcripts
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
Keep Reading →
April 23 - Hedge Funds, Market Movers, News
US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets.
Keep Reading →
April 23 - Hedge Funds, News
Navellier & Associates is an independent money management firm founded in 1987 by renowned growth analyst Louis Navellier.
Keep Reading →
April 16 - Hedge Funds, News
"They wipe out these gains pretty easily, don't they? Just like that, the sellers take away months, if not years, of profits because they want to get ahead of a potential recession...
Keep Reading →
March 15 - Hedge Funds, News
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript March 3, 2025ADMA Biologics, Inc. misses on earnings expectations.
Keep Reading →
March 4 - News, Transcripts
Jim Cramer, host of Mad Money, recently discussed some of the significant challenges the alcohol industry is facing.
Keep Reading →
January 30 - Hedge Funds, News
Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the current market momentum and emphasize the need for investors...
Keep Reading →
January 18 - Hedge Funds, News, Tech
Most experts agree that the AI wave is not over yet.
Keep Reading →
January 9 - Hedge Funds, News
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
Keep Reading →
December 31 - Hedge Funds, News
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript November 7, 2024ADMA Biologics, Inc. beats earnings expectations.
Keep Reading →
November 9 - News, Transcripts
The recent Fed rate cut has made the market cautiously optimistic. Despite the unusual timing, historical data suggests a continued upward trend.
Keep Reading →
September 25 - Hedge Funds, News
ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2024 Earnings Call Transcript August 8, 2024ADMA Biologics, Inc. beats earnings expectations.
Keep Reading →
August 9 - News, Transcripts
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05.
Keep Reading →
May 10 - News, Transcripts
ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $0.02.
Keep Reading →
February 29 - News, Transcripts
Operator: Good afternoon, and welcome to the ADMA Biologics Third Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, November 8, 2023.
Keep Reading →
November 10 - News, Transcripts
Operator: Good afternoon, and welcome to the ADMA Biologics Second Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, August 9, 2023.
Keep Reading →
August 11 - News, Transcripts
Operator: Good afternoon. And welcome to the ADMA Biologics First Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, May 10, 2023.
Keep Reading →
May 14 - News, Transcripts
In this article, we will be taking a look at the 5 best stocks to buy for a stock market game.
Keep Reading →
May 5 - Hedge Funds, News
New Jersey is one of the smallest states in the U.S. in terms of area.
Keep Reading →
April 25 - News, Retirement
ADMA Biologics, Inc. (NASDAQ:ADMA) is a biotech company whose shares have shown a remarkable performance over the past 12 months, gaining about 80% in value.
Keep Reading →
April 16 - Hedge Funds, News